Infection hospitalisation in systemic lupus in Sweden

OBJECTIVE: Immune dysregulation in SLE and the corresponding immune-modulating and immunosuppressive nature of the treatments may play key roles in infection risk. We compared serious infection rates among individuals with incident SLE with the general population, and examined the role of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Simard, Julia F, Rossides, Marios, Gunnarsson, Iva, Svenungsson, Elisabet, Arkema, Elizabeth V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Epidemiology and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444249/
https://www.ncbi.nlm.nih.gov/pubmed/34526357
http://dx.doi.org/10.1136/lupus-2021-000510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444249/
https://www.ncbi.nlm.nih.gov/pubmed/34526357
http://dx.doi.org/10.1136/lupus-2021-000510

Ejemplares similares